SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017650
Filing Date
2017-08-14
Accepted
2017-08-14 16:18:05
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-10q_20170630.htm 10-Q 1246316
2 EX-3.1 dare-ex31_263.htm EX-3.1 94518
3 EX-31.1 dare-ex311_12.htm EX-31.1 17670
4 EX-31.2 dare-ex312_7.htm EX-31.2 17497
5 EX-32.1 dare-ex321_6.htm EX-32.1 6932
6 EX-32.2 dare-ex322_8.htm EX-32.2 7168
  Complete submission text file 0001564590-17-017650.txt   3843102

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dare-20170630.xml EX-101.INS 610312
8 XBRL TAXONOMY EXTENSION SCHEMA dare-20170630.xsd EX-101.SCH 32364
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dare-20170630_cal.xml EX-101.CAL 28927
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dare-20170630_def.xml EX-101.DEF 102364
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dare-20170630_lab.xml EX-101.LAB 267950
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dare-20170630_pre.xml EX-101.PRE 199533
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 171030395
SIC: 2834 Pharmaceutical Preparations